Nitric Oxide Prodrug JS-K Inhibits Ubiquitin E1 and Kills Tumor Cells Retaining Wild Type p53

Ítems similars

• Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells
  per: Liu, Jie, et al.
  Publicat: (2009)
• Mechanism of action for the cytotoxic effects of the nitric oxide prodrug JS-K in murine erythroleukemia cells
  per: Kaczmarek, Monika Z., et al.
  Publicat: (2013)
• TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
  per: Simeone, Ann-Marie, et al.
  Publicat: (2008)
• Stabilization of the Nitric Oxide (NO) Prodrugs and Anti-Cancer Leads, PABA/NO and Double JS-K through Incorporation into PEG-Protected Nanoparticles
  per: Kumar, Varun, et al.
  Publicat: (2010)
• JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells
  per: McMURTRY, VANITY, et al.
  Publicat: (2011)